NICODERM CQ 14 mg/24h (Nicotine PATCH, EXTENDED RELEASE) 14 mg/24h

NICODERM CQ 14 mg/24h is a transdermal patch designed to help manage nicotine dependence. This extended-release patch delivers nicotine steadily through the skin, aiding in smoking cessation efforts.

Strength

14 mg/24h

Pack Size

14 PATCH in 1 CARTON (0135-0195-02) / 24 h in 1 PATCH

Manufacturer / TM Owner

Haleon US Holdings LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NICODERM CQ 14 mg/24h is used as part of a smoking cessation program. The patch provides a controlled release of nicotine to help reduce withdrawal symptoms and cravings. It is typically used by individuals who are trying to quit smoking and need support in managing their nicotine intake.

Side Effects

Common effects of NICODERM CQ 14 mg/24h may include skin irritation at the application site, headaches, and dizziness. Some users may also experience nausea or insomnia. These effects vary among individuals and are generally mild.

Precautions & Warnings

NICODERM CQ 14 mg/24h should be used as directed. Avoid applying the patch to broken or irritated skin. It is important to follow the instructions provided with the product to ensure safe and effective use. Consult a healthcare professional if you have any concerns.

Avoid Interactions

NICODERM CQ 14 mg/24h may interact with certain medications, including those that affect heart rate or blood pressure. It is advisable to inform your healthcare provider about all medications you are taking before using this patch. Avoid smoking while using the patch, as it can increase the risk of side effects.

Frequently Asked Questions

NICODERM CQ 14 mg/24h is used to help manage nicotine dependence and support smoking cessation efforts.

The patch delivers a controlled amount of nicotine through the skin to help reduce withdrawal symptoms and cravings.

Yes, skin irritation at the application site is a common effect of using the NICODERM CQ patch.

Apply the patch to clean, dry skin and avoid areas with hair or irritation. Follow the instructions provided with the product.

It is not recommended to smoke while using the patch, as it can increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.